Certara Inc (CERT)

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Certara to Participate in Upcoming Investor Conferences

RADNOR, Pa., May 18, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Certara Reports First Quarter 2026 Financial Results

RADNOR, Pa., May 11, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed...

Altasciences und Certara kündigen strategische Partnerschaft zur Beschleunigung der frühen Phase der Arzneimittelentwicklung an

Altasciences , ein vollständig integriertes Unternehmen für Arzneimittelentwicklungslösungen, und Certara (Nasdaq: CERT),, ein Weltmarktführer im...

Altasciences et Certara annoncent un partenariat stratégique visant à accélérer le développement de médicaments en phase précoce

Altasciences , une organisation proposant des solutions de développement de médicaments pleinement intégrées, et Certara (Nasdaq : CERT), leader...

Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development

Altasciences, a fully integrated drug development solution company, and Certara (Nasdaq: CERT), a global leader in model-informed drug...